🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,589 results for “Pharma” Clear

  1. Omacetaxine

    Teva Pharma GmbH

    Myelodysplastic Syndromes

    phase 2 small molecule terminated

    1 trial

  2. Omacetaxine

    Teva Pharma GmbH

    Leukemia

    phase 2 small molecule terminated

    2 trials

  3. Omacetaxine mepesuccinate

    Teva Pharma GmbH

    Chronic Myeloid Leukemia

    phase 2 small molecule completed

    3 trials

  4. Omega 3 pentaenoic acid

    Matinas BioPharma Holdings

    Hypertriglyceridemia

    phase 2 small molecule completed

    1 trial

  5. Opaganib

    RedHill Biopharma

    Coronavirus Infections

    phase 2 small molecule completed

    1 trial

  6. Open-Label

    Jazz Pharmaceuticals Ireland Limited

    Chronic Obstructive Pulmonary Disease

    phase 2 small molecule terminated

    1 trial

  7. Open-label, safety, tolerability and proof of concept study to evaluate the use of ANXV (recombinant human Annexin A5 protein) in the treatment of patients with either Diabetic Retinopathy or recent onset Retinal Vein Occlusion

    Lacuna Pharma Pty Ltd

    Diabetic Retinopathy, Retinal Vein Occlusion

    phase 2 other active

    1 trial

  8. Oral CEP-701

    Teva Pharma GmbH

    Myeloma

    phase 2 small molecule terminated

    1 trial

  9. Oral Encochleated Amphotericin B (CAMB)

    Matinas BioPharma Holdings

    Vulvovaginal Candidiases

    phase 2 small molecule terminated

    1 trial

  10. Oral Encochleated Amphotericin B (CAMB)

    Matinas BioPharma Holdings

    Acute Myeloid Leukemia

    phase 2 small molecule terminated

    1 trial

  11. Oral Encochleated Amphotericin B (CAMB)

    Matinas BioPharma Holdings

    Vulvovaginitis

    phase 2 small molecule completed

    1 trial

  12. Oral Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Scleroderma, Diffuse

    phase 2 small molecule active

    1 trial

  13. Oral Insulin

    ORAMED PHARMACEUTICALS INC.

    Non-Alcoholic Steatohepatitis (NASH)

    phase 2 mab completed

    1 trial

  14. Osilodrostat

    Novartis Pharmaceuticals

    Cushing's Syndrome

    phase 2 small molecule completed

    1 trial

  15. Oxbryta 500 mg film-coated tablets

    Pari Pharma GmbH

    sickle cell disease

    phase 2 small molecule active

    1 trial

  16. P-1037

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 2 small molecule completed

    1 trial

  17. PALONOSETRON, FAMOTIDINE, DEXAMETHASONE PHOSPHATE, Plitidepsin, DEXCHLORPHENIRAMINE, PLACEBO

    MEDA Pharma GmbH & Co. KG

    post-COVID-19 Condition (PCC)

    phase 2 small molecule active

    1 trial

  18. PARACETAMOL, Placebo to QUC398 150 mg/1 mL Solution for injection, QUC398, Paracetamol/Codeine phosphate hemihydrate Accord 500 mg/30 mg tablets

    Novartis Pharmaceuticals

    Knee osteoarthritis

    phase 2 small molecule active

    1 trial

  19. PC14586

    PMV Pharmaceuticals

    Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation

    phase 2 small molecule active

    1 trial

  20. PCI

    Rhythm Pharmaceuticals Netherlands B.V.

    Myocardial Infarction

    phase 2 other completed

    1 trial

  21. PCS12852

    Processa Pharmaceuticals

    Gastroparesis

    phase 2 small molecule completed

    1 trial

  22. PCS499

    Processa Pharmaceuticals

    Necrobiosis Lipoidica

    phase 2 small molecule completed

    2 trials

  23. PCS6422 and capecitabine

    Processa Pharmaceuticals

    Breast Cancer

    phase 2 small molecule active

    1 trial

  24. PDC-1421 Capsule

    ABVC BIOPHARMA, INC.

    Attention-Deficit Hyperactivity Disorder (ADHD)

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources